vcvibes

Rivervest Venture Partners

SEC exempt reporting adviser (venture capital exemption).

Website
HTTP://WWW.RIVERVEST.COM
HQ
MO
Open their pitch form

RiverVest Venture Partners is a venture capital firm that builds life science companies to address significant unmet needs of patients. It was formed in September 2000 and raised its first fund, which later produced commercial products treating patients. The firm also runs the 3x5 Special Opportunity Fund, a joint venture with Arnerich Massena, which makes a concentrated portfolio of later-stage life science and natural resource and infrastructure investments. RiverVest Fund II launched with the same strategy.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoesHistorically (to 2020)
StagesNot statedNot enough dated dealsSeries A, Series B, Growth
SectorsBiotech, Medical devicesNot enough dated dealsBiotech, Healthtech, Medical devices, Manufacturing, Life sciences and research tools
RegionsNot statedNot enough dated dealsCA, OH

Says: what the firm's funds state. Does: from 1 dated deal in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

YearDealsTop sectors
20001Healthtech
20011Healthtech, Manufacturing
20032Healthtech, Medical devices
20042Healthtech, Biotech, Medical devices
20051Biotech, Healthtech, Life sciences and research tools
20062Biotech, Healthtech, Manufacturing
20072Healthtech, Biotech, Medical devices
20082Biotech, Medical devices, Healthtech
20091Biotech, Manufacturing, Medical devices
20105Biotech, Healthtech, Manufacturing
20112Biotech, Life sciences and research tools, Healthtech
20122Biotech, Energy, Hardware
20134Biotech, Healthtech, Life sciences and research tools
20147Biotech, Healthtech, Manufacturing
20152Biotech, Healthtech
20163Biotech, Healthtech, Life sciences and research tools
20176Biotech, Healthtech, Medical devices
20185Biotech, Healthtech, Life sciences and research tools
20194Biotech, Healthtech
20205Biotech, Healthtech, Life sciences and research tools

Stage mix over time

2010 Series B: 12010 Growth: 2102011 Series A: 2112012 Series A: 12012 Growth: 1122013 Series A: 12013 Series B: 12013 Growth: 1132014 Series A: 22014 Series B: 22014 Growth: 2142015 Series A: 12015 Series B: 1152016 Series A: 22016 Growth: 1162017 Series A: 22017 Series B: 22017 Growth: 2172018 Series A: 32018 Series B: 2182019 Series A: 12019 Series B: 3192020 Series A: 12020 Series B: 32020 Growth: 120212223242526
  • Pre-seed
  • Seed
  • Series A
  • Series B
  • Growth
Share of rounds by stage, per year. Striped years have fewer than 3 rounds.Historical focus (through 2020), derived from historical deal data.
Rounds by stage and year
YearPre-seedSeedSeries ASeries BGrowth
201000012
201100200
201200101
201300111
201400222
201500110
201600201
201700222
201800320
201900130
202000131
202100000
202200000
202300000
202400000
202500000
202600000

02 · Fund history

FundYearSizeStatus
RiverVest Venture Fund V, L.P.2020$275M (Form D)Follow-ons only

03 · People across funds

04 · Recent deals

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. HTTP://WWW.RIVERVEST.COM
  2. https://rivervest.com/
  3. https://rivervest.com/about/
  4. https://rivervest.com/news/
  5. https://rivervest.com/team/
  6. https://rivervest.com/2025/12/09/portfolio-company-bluejay-therapeutics-to-be-acquired-by-mirum-pharmaceuticals/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 25, 2026